PMC:7787218 / 17737-18133 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7787218","sourcedb":"PMC","sourceid":"7787218","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7787218","text":"Intramuscular Post-EUA 0.43 mg ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 0.05 mg2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 0.09 mg 1,2-distearoyl-sn-glycero-3-phosphocholine, and 0.2 mg cholesterol, 0.01 mg potassium chloride, 0.01 mg monobasic potassium phosphate, 0.36 mg sodium chloride, 0.07 mg dibasic sodium phosphate dihydrate, and 6 mg sucrose.","divisions":[{"label":"p","span":{"begin":0,"end":13}},{"label":"td","span":{"begin":15,"end":23}}],"tracks":[{"project":"LitCovid-sentences","denotations":[{"id":"T77","span":{"begin":0,"end":396},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T77","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-sentences","color":"#ecc393","default":true}]}]}}